Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 24.61% | -9.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.61% | -9.00% | |||
| Cost of Revenue | 24.27% | -9.61% | |||
| Gross Profit | 24.78% | -8.71% | |||
| SG&A Expenses | 25.02% | -4.20% | |||
| Depreciation & Amortization | 4.82% | -3.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.27% | -6.18% | |||
| Operating Income | 31.45% | -21.09% | |||
| Income Before Tax | 81.52% | 320.27% | |||
| Income Tax Expenses | -152.02% | 1,634.60% | |||
| Earnings from Continuing Operations | 168.81% | 184.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 168.81% | 184.71% | |||
| EBIT | 31.45% | -21.09% | |||
| EBITDA | 21.56% | -14.71% | |||
| EPS Basic | 171.89% | 184.58% | |||
| Normalized Basic EPS | 26.49% | 18.19% | |||
| EPS Diluted | 175.93% | 184.21% | |||
| Normalized Diluted EPS | 28.03% | 18.15% | |||
| Average Basic Shares Outstanding | -1.13% | 0.02% | |||
| Average Diluted Shares Outstanding | -2.34% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||